Search
Twist Bioscience Corp
TWSTAdd to Watchlist
91.550USD
+0.220+0.24%
Close 07-31 16:00（ET）Quotes delayed by 15 min
5.69BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Twist Bioscience Corp is 9.00, ranking 4 out of 155 in the Pharmaceuticals industry. The average price target is 36.00, with a high of 57.17 and a low of 32.00.
Analyst Rating
Based on
10
analysts
Strong Buy
Current Rating
94.333
Target Price
+10.37%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Twist Bioscience Corp
TWST
10
Amgen Inc
AMGN
37
Biogen Inc
BIIB
37
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
32
Pfizer Inc
PFE
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Twist Bioscience Corp's expected revenue for the next quarter?
Twist Bioscience Corp's expected revenue is 114.49M.
What is Twist Bioscience Corp's price target?
Analysts forecast that Twist Bioscience Corp's price target is USD 36.00, with the highest forecast at USD 57.17 and the lowest forecast at USD 32.00.
How have Twist Bioscience CorpTWST's recent earnings per share performed?
The market expectation was USD -0.71, while Twist Bioscience CorpTWST's earnings per share (EPS) for the previous quarter was USD -0.50. EPS for the next quarter is expected at USD -0.49.
What is the analyst rating for Twist Bioscience Corp?
Based on the ratings of Twist Bioscience Corp's stock from 10 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.